Martin de Kort

681 citations

27 papers · 499 indexed · h-index 13

Co-authors: Gijs A. van der Marel Jacques H. van Boom Rogier C. Buijsman C. A. A. VAN BOECKEL A. Rob P.M. Valentijn Fred van Leeuwen Barry V. L. Potter Piet Borst
Topics: Carbohydrate Chemistry and Synthesis (12 papers)Synthetic Organic Chemistry Methods (4 papers)Genomics and Rare Diseases (3 papers)
Cited by: Organic Chemistry Internal Medicine Molecular Biology
Journals: The EMBO Journal Nature Reviews Drug Discovery Analytical Biochemistry
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Martin de Kort

25 papers receiving 482 citations

Peers

Countries citing papers authored by Martin de Kort

Since Specialization

Citations

This map shows the geographic impact of Martin de Kort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin de Kort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin de Kort more than expected).

Fields of papers citing papers by Martin de Kort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin de Kort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin de Kort. The network helps show where Martin de Kort may publish in the future.

Co-authorship network of co-authors of Martin de Kort

This figure shows the co-authorship network connecting the top 25 collaborators of Martin de Kort. A scholar is included among the top collaborators of Martin de Kort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin de Kort. Martin de Kort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SIMPATHIC: Accelerating drug repurposing for rare diseases by exploiting SIMilarities in clinical and molecular PATHology 2025 ·Molecular Genetics and Metabolism ·Clara van Karnebeek,(unknown),(unknown),Ibrahim Boussaad,Martina C. Cornel,Joanna IntHout,Martin de Kort,Sofia Oliveira‐Martins,Alessandro Prigione,Tessel Rigter,Kit C. B. Roes,(unknown),Raymond G. Schipper,Mark D. Wilkinson,Peter A.C. ’t Hoen	0
2	Drug repurposing for rare: progress and opportunities for the rare disease community 2024 ·Frontiers in Medicine ·Anneliene Hechtelt Jonker,Daniel O’Connor,(unknown),(unknown),Μαρία Γώγου,Peter A.C. ’t Hoen,Martin de Kort,(unknown),(unknown),Anna M.G. Pasmooij	28
3	Synthesis and Evaluation of a Series of Long‐Acting Glucagon‐Like Peptide‐1 (GLP‐1) Pentasaccharide Conjugates for the Treatment of Type 2 Diabetes 2015 ·ChemMedChem ·Nigel Irwin,Steven Patterson,Martin de Kort,R. Charlotte Moffett,(unknown),Wim H.A. Dokter,Ebo Bos,André M. M. Miltenburg,Peter R. Flatt	7
4	Pharmacological characterization and antidiabetic activity of a long‐acting glucagon‐like peptide‐1 analogue conjugated to an antithrombin III ‐binding pentasaccharide 2015 ·Diabetes Obesity and Metabolism ·Steven Patterson,Martin de Kort,Nigel Irwin,R. Charlotte Moffett,Wim H.A. Dokter,Ebo Bos,A. M. M. Miltenburg,Peter R. Flatt	6
5	From heparin to EP217609: The long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile 2009 ·Thrombosis and Haemostasis ·Vanessa Nancy-Portebois,Guy Dubreucq,(unknown),Martin de Kort,C. A. A. VAN BOECKEL,(unknown),(unknown),(unknown),(unknown)	37
6	Conjugation of ATIII‐Binding Pentasaccharides to Extend the Half‐Life of Proteins: Long‐Acting Insulin 2008 ·ChemMedChem ·Martin de Kort,(unknown),(unknown),Ebo Bos,Michel H. M. Eppink,(unknown),G.M.T. Vogel,Wim H.A. Dokter,Maarten Honing,(unknown),(unknown),Jac C.H.M. Wijkmans,C. A. A. VAN BOECKEL	14
7	Synthetic heparin derivatives as new anticoagulant drugs 2005 ·Drug Discovery Today ·Martin de Kort,Rogier C. Buijsman,C. A. A. VAN BOECKEL	62
8	A Versatile Approach Towards Regioselective Platinated DNA Sequences 2003 ·Chemistry - A European Journal ·(unknown),Martin de Kort,Nico J. Meeuwenoord,Hans den Dulk,Gijs A. van der Marel,Jacques H. van Boom,J. Reedijk	6
9	Conformational analysis of cyclophostin and designed analogs in comparison with the potent IP3 receptor agonist adenophostin A. 2001 ·PubMed ·(unknown),Martin de Kort,R. A. John Challiss,G. A. VAN DER MAREL,Jacques H. van Boom,Shuichi Miyamoto	2
10	Chemical and Enzymatic Synthesis of DNA Fragments Containing 5-(β-D-Glucopyranosyloxymethyl)-2′-deoxycytidine − a Modified Nucleoside in T4 Phage DNA 2001 ·European Journal of Organic Chemistry ·Martin de Kort,(unknown),(unknown),Nico J. Meeuwenoord,Gijsbert A. van der Marel,Wolfgang Rüger,(unknown)	20
11	Synthesis of Potent Agonists of the d-myo-Inositol 1,4,5-Trisphosphate Receptor Based on Clustered Disaccharide Polyphosphate Analogues of Adenophostin A 2000 ·Journal of Medicinal Chemistry ·Martin de Kort,(unknown),A. Rob P.M. Valentijn,Gijs A. van der Marel,Barry V. L. Potter,Colin W. Taylor,Jacques H. van Boom	70
12	Spirophostins: Conformationally Restricted Analogues of Adenophostin A 2000 ·Chemistry - A European Journal ·Martin de Kort,(unknown),A. Rob P.M. Valentijn,R. A. John Challiss,(unknown),Shuichi Miyamoto,(unknown),Jacques H. van Boom	14
13	Synthesis and Biological Evaluation of Cyclophostin: A 5′,6″-Tethered Analog of Adenophostin A 2000 ·Tetrahedron ·Martin de Kort,(unknown),Herman S. Overkleeft,R. A. John Challiss,(unknown),Shuichi Miyamoto,Gijs A. van der Marel,Jacques H. van Boom	14
14	The modified base J is the target for a novelDNA-binding protein in kinetoplastid protozoans 1999 ·The EMBO Journal ·Mike Cross,Rudo Kieft,Robert Sabatini,Matthias Wilm,Martin de Kort,Gijs A. van der Marel,Jacques H. van Boom,Fred van Leeuwen,Piet Borst	61
15	Synthesis of Oligodeoxynucleotides Containing 5-(β-D-Glucopyranosyloxymethyl)-2′-deoxyuridine, a Modified Nucleoside in the DNA ofTrypanosoma Brucei 1999 ·European Journal of Organic Chemistry ·Martin de Kort,(unknown),(unknown),Gijs A. van der Marel,Jacques H. van Boom	28
16	The Modified DNA Base β-d-Glucosylhydroxymethyluracil Confers Resistance to Micrococcal Nuclease and Is Incompletely Recovered by32P-Postlabeling 1998 ·Analytical Biochemistry ·Fred van Leeuwen,Martin de Kort,Gijs A. van der Marel,Jacques H. van Boom,Piet Borst	18
17	Synthesis of Clustered Disaccharide Polyphosphate Analogues of Adenophostin A 1997 ·Tetrahedron Letters ·Martin de Kort,A. Rob P.M. Valentijn,Gijs A. van der Marel,Jacques H. van Boom	16
18	Stability of Pyridiniumylquinones to Aqueous Media: The Formation of Pyridinium−Oxy Zwitterionic Quinones 1996 ·The Journal of Organic Chemistry ·Andrew S. Koch,(unknown),(unknown),Martin de Kort,(unknown)	11
19	Use of a Novel α-Hydroxyethylating Reagent in the Stereoselective Synthesis of Lincosamine 1996 ·The Journal of Organic Chemistry ·Floris L. van Delft,Martin de Kort,Gijs A. van der Marel,Jacques H. van Boom	12
20	Stereocontrolled hydroxymethylation of carbohydrate imines: Formal synthesis of destomic acid and lincosamine 1994 ·Tetrahedron Asymmetry ·Floris L. van Delft,Martin de Kort,Gijs A. van der Marel,Jacques H. van Boom	11

About Martin de Kort

Martin de Kort is a scholar working on Organic Chemistry, Toxicology and Pharmacology, having authored 27 papers that have together received 499 indexed citations. Recurring topics across this work include Carbohydrate Chemistry and Synthesis (12 papers), Synthetic Organic Chemistry Methods (4 papers) and Genomics and Rare Diseases (3 papers). The work is most often cited by research in Organic Chemistry (225 citations), Internal Medicine (18 citations) and Molecular Biology (246 citations). Martin de Kort has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Gijs A. van der Marel, Jacques H. van Boom, Rogier C. Buijsman, C. A. A. VAN BOECKEL, A. Rob P.M. Valentijn, Fred van Leeuwen, Barry V. L. Potter, Piet Borst, Colin W. Taylor and Robert Sabatini. Their work appears in journals such as The EMBO Journal, Nature Reviews Drug Discovery and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact